Dr. Harting is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
901 McClintock Dr
Ste 202
Burr Ridge, IL 60527Phone+1 888-220-6432Fax+1 630-654-4253
Education & Training
Rush University Medical CenterFellowship, Infectious Disease, 2006 - 2008- Rush University Medical CenterResidency, Internal Medicine, 2000 - 2004
Saint Louis University School of MedicineClass of 2000
Certifications & Licensure
IL State Medical License 2003 - 2026
CT State Medical License 2022 - 2025
WA State Medical License 2018 - 2025- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 16 citationsTocilizumab as a Therapeutic Agent for Critically Ill Patients Infected with SARS-CoV-2.Russell M. Petrak, Nathan C. Skorodin, Nicholas W. Van Hise, Robert M. Fliegelman, Jonathan Pinsky
Clinical and Translational Science. 2021-11-01 - 10 citationsEarly Tocilizumab Dosing Is Associated With Improved Survival in Critically Ill Patients Infected With Severe Acute Respiratory Syndrome Coronavirus-2Russell M. Petrak, Nicholas W. Van Hise, Nathan C. Skorodin, Robert M. Fliegelman, Vishnu Chundi
Critical Care Explorations. 2021-03-29 - 23 citationsValue and Clinical Impact of an Infectious Disease-Supervised Outpatient Parenteral Antibiotic Therapy Program.Russell M. Petrak, Nathan C. Skorodin, Robert M. Fliegelman, David W. Hines, Vishnu Chundi
Open Forum Infectious Diseases. 2016-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
